Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coagulation in sepsis.

Tonya Jagneaux1, David E Taylor, Stephen P Kantrow

  • 1Section of Pulmonary and Critical Care Medicine, Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA.

The American Journal of the Medical Sciences
|October 16, 2004
PubMed
Summary

Sepsis-associated coagulopathy can cause tissue damage or abnormal clotting. Anticoagulant therapies are being explored to manage sepsis by targeting excessive coagulation and inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging Healthcare Analytics to Uncover Social Determinants of Health Disparities in Congestive Heart Failure.

Cureus·2026
Same author

Correction: Eliminating the AI digital divide by building local capacity.

PLOS digital health·2025
Same author

Eliminating the AI digital divide by building local capacity.

PLOS digital health·2025
Same author

Impact of social determinants of health on sepsis outcomes: a retrospective study of a single centre in the USA.

BMJ open·2025
Same author

Temporal trends of a cellular host response test for sepsis and a comparison with selected biomarkers of inflammation and infection.

Scientific reports·2025
Same author

Large Language Model Symptom Identification From Clinical Text: Multicenter Study.

Journal of medical Internet research·2025

Area of Science:

  • Coagulation and Inflammation Biology
  • Infectious Disease Pathophysiology
  • Critical Care Medicine

Background:

  • Invasive infections activate the coagulation cascade, potentially leading to purpura fulminans or isolated clotting abnormalities.
  • Severe coagulopathy in sepsis correlates with organ dysfunction and mortality, yet its precise role remains unclear.
  • Understanding the interplay between endothelial injury, coagulation, and inflammation is crucial for sepsis management.

Purpose of the Study:

  • To review clotting abnormalities observed during sepsis.
  • To discuss clinical experiences with anticoagulant strategies in sepsis management.
  • To explore the therapeutic potential of manipulating the coagulation system in sepsis.

Main Methods:

  • Literature review of studies on sepsis-induced coagulopathy.

Related Experiment Videos

  • Analysis of clinical observations regarding anticoagulant therapies in septic patients.
  • Examination of the role of activated protein C in modulating sepsis-related pathways.

    • Main Results:

    • Activation of coagulation during sepsis can lead to severe outcomes like purpura fulminans.
    • Coagulopathy is a significant factor in sepsis pathophysiology, linked to poor prognosis.
    • Therapeutic anticoagulation strategies are increasingly recognized as important in sepsis management.

    Conclusions:

    • Coagulation abnormalities are a critical component of sepsis.
    • Targeting excessive coagulation with anticoagulant strategies shows therapeutic promise.
    • Further research into the interactions between coagulation, inflammation, and endothelial injury is warranted for improved sepsis treatment.